Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sjögren's syndrome patients;Uso oral do óleo de linhaça (Linum usitatissimum) no tratamento do olho seco de pacientes portadores da síndrome de Sjögren

Arquivos Brasileiros de Oftalmologia

Volumn 70, Issue 4, 2007, Pages 649-655

  Pinheiro Jr , Manuel Neuzimar ^a,e   dos Santos, Procópio Miguel ^a,b   dos Santos, Regina Cândido Ribeiro ^a,b   Barros, Jeison de Nadai ^b   Passos, Luiz Fernando ^c   Cardoso Neto, José ^c,d  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UFAM ^*  (Brazil)

Author keywords

Dry eye syndromes; Flaxseed oil therapeutic use; Keratitis, Sj gren's syndrome; Keratoconjunctivitis sicca drug therapy; Tears metabolism

Indexed keywords

EID: 37349005183     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492007000400016     Document Type: Article

References (35)

1. Nishiwaki-Dantas MC. Atualização em olho seco. Arq Bras Oftalmol. 1999; 62(1):101-5.
2. Daniels TE. Sjögren's syndrome: clinical spectrum and current diagnostic controversies. Adv Dent Res. 1996;10(1):3-8.
3. Kara-José N, Almeida GV, org. Senilidade ocular. São Paulo: Roca; 2001.
4. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Opthalmol. 2000;118(9):1264-8.
5. Whitcher JP. Clinical diagnosis of the dry eye. Int Ophthalmol Clin. 1987;27 (1):7-24.
6. Toda I, Tsubota, K. Practical double vital staining for ocular surface evaluation. Cornea. 1993;12(4):366-7.
7. Van Bijsterveld OP. Diagnostic tests in the sicca syndrome. Arch Ophthalmol. 1969;82(1):10-4.
8. Brown NA, Bron AJ, Harding JJ, Dewar HM. Nutrition supplements and the eye. Eye. 1998;12(Pt 1):127-33.
9. Ambrióso RJ, Stelzner SK, Boerner CF, Honan PR, McIntyre DJ. Nutrition and dry eye: the role of lipids. Review Refract Surg. 2002:29-32.
10. Barabino S, Rolando M, Camicione P, Ravera G, Zanardi S, Giuffrida S, et al. Systemic linoleic and gamina-linoleic acid therapy in dry eye syndrome with a inflammatory component. Cornea. 2003;22(2):97-101.
11. Simo?oulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999;70(3 Suppl.):560S-9S.
12. Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty adds and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr. 2005;82(4):987-93.
13. Clark WF, Kortas C, Heidenhein AP, Garland J, Spanner E, Parbtani A. Flaxseed in lupus nephritis: a two-year nonplacebo-controlled crossover study. J Am Coll Nutr. 2001;20(2 Suppl.):143-8.
14. Hasler CM, Kundrat S, Wool D. Functional foods and cardiovascular disease. Curr Atheroscler Rep. 2000;2(6):467-75.
15. Lemay A, Dodin S, Kadri N, Jacques H, Forest JC. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol. 2002;100(3):495-504.
16. Dabrosin C, Chen J, Wang L, Thompson LU. Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. Cancer Lett. 2002;185(1):31-7.
17. Hutchins AM, Martini MC, Olson BA, Thomas W, Slavin JL. Flaxseed consumption influences endogenous hormone concentration in postmenopausal women. Nutr Cancer. 2001;39(1):58-65.
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-24.
19. Rolando M, Macri A, Carlandrea T, Calabria G. Use of a questionnaire for the diagnosis of tear-reiated ocular surface disease. Adv Exp Med Biol. 1998;438: 821-5.
20. Vitali C, Bombardieri S, Johnson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH; European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjorgren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554-8.
21. Murube J. Ojo Seco. Quito-Equador: Tecnimedia; 1997.
22. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000; 118(5):615-21. Comment in: Arch Ophthalmol. 2001;119(3):456.
23. Barros JN, Mascaro VL, Gomes JA, Freitas D, Lima AL. Citologia de impressão da superfície ocular. técnica de exame e de coloração. Arq Bras Oftalmol. 2001;64(2):127-31.
24. Bueno de Camargo G, Nishiwaki-Dantas MC, Barros JN, Lake JC. Citologia. de impressão on ceratoconjuntivite primaveril. Arq Bras Oftalmol. 2004;67 (6):877-91.
25. Nelson JD, Havenes VR, Cameron JD. Cellulose acetate impressions of the ocular surface. Dry eye states. Arch Ophthalmol. 1993;101(12):1869-72.
26. Zurier RB. Gammalinoleic acid treatment of rheumatoid arthritis. In: Kremer J, editor. Medicinal fatty acids in inflammation. Basel: Birkhauser Verlag; 1998. p.29-43.
27. Baudoin C, Brignole F, Becquet F, Pisella PJ, Goguel A. Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci. 1997;38(7):1458-64.
28. Marsh P, Pflugfelder SC. Topical nonpreserved Methylprednisolone therapy for keratoconjuactivitis sisca in Sjögren syndrome. Opthalmology. 1999,106(4):811-6.
29. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology. 2000;107(5):967-74.
30. Aragona P, Giuffrida S, Bucolo C. Tear PGE1 levels in dry eye patients after treatment with essential fatty acids [abstract]. Invest Ophthalmol Vis Sci. 2001;42(Suppl.):259.
31. Pisella PJ, Brignole F, Debbasch C, Lozato PA, Creuzot-Garcher C, Bara J, et al. Flow cytometric analysis of conjunctival epithelium in ocular rosácea and keratoconjunctivitis sicca. Ophthalmology. 2000;107(10):1841-9.
32. Tsubota K, Fujihara T, Saito K, Takeuchi T. Conjunctival epithelium expression of HLA-DR in dry eye patients. Oplithalmologica. 1999;213(1):16-9.
33. Johanson G, Anderson G, Edwardson S, Björn AL, Manthorpe R, Attström R. Effects of mouthrinses with linseed extract Salinum® without/with chlorhexidine on oral conditions on patients with Sjögren syndrome. A double-blind crossover investigation. Gerodontology. 2001;18(2):87-94.
34. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000;71(1 Suppl.):343-8.
35. Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal function unit in the pathophysiology of dry eye. Exp Eye Res. 2004;78(3):409-16.